中国医药(600056.SH)子公司获得注射用特利加压素药品注册批件

智通财经2023-03-07

智通财经APP讯，中国医药(600056.SH)发布公告，近日，公司下属全资子公司通用三洋收到国家药监局核准签发的一份注射用特利加压素《药品注册证书》。该药品适用于胃肠道、泌尿生殖系统、术后出血的治疗，以及妇科手术的局部应用、肝肾综合征、肝移植患者术前术后肝肾综合征的治疗或预防等和顽固性(对儿茶酚胺抵抗性)休克等的治疗。根据米内网数据库国内市场样本医院用药销售统计显示，2021年注射用特利加压素...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2317546873?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2023-03-07 17:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2317546873","market":"hk","top_or_hot":-1,"title":"中国医药(600056.SH)子公司获得注射用特利加压素药品注册批件","media":"智通财经","content":"<div>\n<p>智通财经APP讯，中国医药(600056.SH)发布公告，近日，公司下属全资子公司通用三洋收到国家药监局核准签发的一份注射用特利加压素《药品注册证书》。该药品适用于胃肠道、泌尿生殖系统、术后出血的治疗，以及妇科手术的局部应用、肝肾综合征、肝移植患者术前术后肝肾综合征的治疗或预防等和顽固性(对儿茶酚胺抵抗性)休克等的治疗。根据米内网数据库国内市场样本医院用药销售统计显示，2021年注射用特利加压素...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/887968.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>中国医药(600056.SH)子公司获得注射用特利加压素药品注册批件</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n中国医药(600056.SH)子公司获得注射用特利加压素药品注册批件\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-03-07 17:43 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/887968.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，中国医药(600056.SH)发布公告，近日，公司下属全资子公司通用三洋收到国家药监局核准签发的一份注射用特利加压素《药品注册证书》。该药品适用于胃肠道、泌尿生殖系统、术后出血的治疗，以及妇科手术的局部应用、肝肾综合征、肝移植患者术前术后肝肾综合征的治疗或预防等和顽固性(对儿茶酚胺抵抗性)休克等的治疗。根据米内网数据库国内市场样本医院用药销售统计显示，2021年注射用特利加压素...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/887968.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0185","symbol_name":"二线龙头","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/887968.html","article_id":"2317546873","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2317546873","pubTimestamp":1678182195,"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，中国医药 发布公告，近日，公司下属全资子公司通用三洋收到国家药监局核准签发的一份注射用特利加压素《药品注册证书》。根据米内网数据库国内市场样本医院用药销售统计显示，2021年注射用特利加压素样本医院销售额约为2.34亿元，2022年上半年销售额约为1.29亿元。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600056":"中国医药","BK0185":"二线龙头","BK0175":"白马股","BK0010":"央企","BK0188":"融资融券","BK0250":"批发","BK0028":"国家队","BK0082":"国资改革"},"translate_title":"The subsidiary of China Pharmaceutical (600056. sh) obtained the registration approval of terlipressin for injection","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600056":1},"content_text":"智通财经APP讯，中国医药(600056.SH)发布公告，近日，公司下属全资子公司通用三洋收到国家药监局核准签发的一份注射用特利加压素《药品注册证书》。该药品适用于胃肠道、泌尿生殖系统、术后出血的治疗，以及妇科手术的局部应用、肝肾综合征、肝移植患者术前术后肝肾综合征的治疗或预防等和顽固性(对儿茶酚胺抵抗性)休克等的治疗。根据米内网数据库国内市场样本医院用药销售统计显示，2021年注射用特利加压素样本医院销售额约为2.34亿元，2022年上半年销售额约为1.29亿元。此次通用三洋注射用特利加压素按照化学药品新注册分类方法获得药品注册批件，有利于提升公司在该药品领域的市场竞争力，同时为公司后续仿制药开发积累了宝贵的经验。","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2317546873"}